Skip to main content

World Cancer Day 2024 With Oncology Data Advisor

In honor of World Cancer Day on February 4, members of the Oncology Data Advisor Fellows Forum and Editorial Board joined forces for a thought-provoking discussion about improving cancer care on a global scale, including treatment access, molecular testing, clinical trial diversity, and patient advocacy worldwide.  

Continue reading

Racial and Socioeconomic Disparities in the CLL Community Oncology Setting With Ira Zackon, MD

Oncology Data Advisor® · Racial and Socioeconomic Disparities in the CLL Community Oncology Setting: Ira Zackon, MD At the recent 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor sat down with Ira Zackon, MD, a Senior Medical Director with Ontada, to discuss his abstract and presentation about racial and socioeconomic disparities experienced by patients in the chronic lymphocytic leukemia (CLL) community oncology and hematology setting, how to comba...

Continue reading

Improving Diversity in Multiple Myeloma Clinical Trials With Craig Cole, MD

At the recent American Society of Hematology (ASH) Annual Meeting, Craig Cole, MD, Assistant Professor at Karmanos Cancer Institute, sat down with Oncology Data Advisor to share his passion for improving diversity in multiple myeloma clinical trials. He discusses the efforts that are currently underway to increase diverse accrual and the importance of raising awareness in order to address this issue both within the community and on a global scale.  

Continue reading

Nurse Navigation and Financial Toxicity Programs to Reduce Socioeconomic Disparities in ALL With Greg Knight, MD

In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Greg Knight, MD, Clinical Assistant Professor of Medicine at Levine Cancer Institute, about his presentation on the impacts of nurse navigation and other supportive care services for reducing socioeconomic disparities in acute lymphoblastic leukemia (ALL) treatment. Additionally, Dr. Knight describes Levine Cancer Institute's Financial Toxicity Tumor Board, the first program of its kind, and shares advice for how other centers can implement similar interventions for mitigating socioeconomic disparities experienced by their patients.  

Continue reading

Reducing Stigmatizing Language in the Electronic Medical Record for More Equitable Care With Alex Boucher, MD

In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Alex Boucher, Director of the Pediatric and Adult Sickle Cell Programs at the University of Minnesota Medical School, about his presentation on racial discrepancies in the use of stigmatizing language in hematology/oncology electronic medical records. Dr. Boucher explains the impact that stigmatizing language can have on patient care and ways to raise awareness for mitigating its use.  

Continue reading

Pioneering Digital Approaches to Address Racial/Ethnic Cancer Survivorship Disparities With Eun-Ok Im, PhD, MPH, RN, CNS, FAAN

Eun-Ok Im, PhD, MPH, RN, CNS, FAAN, was recently named as the recipient of the 2023 Oncology Nursing Society (ONS) Distinguished Nurse Researcher Award. At this past ONS Congress, Dr. Im gave a presentation on her pioneering use of technology and Internet-based approaches to address racial and ethnic survivorship disparities in the cancer survivorship experience, which she has been among the first to research over the course of her career. In this interview, she provides the background behind this approach and how it has been used to improve survivorship experience for racial/ethnic minority cancer patients. 

Continue reading

Bridging Disparities in Breast Cancer Morbidity and Mortality in Women of Color With Jessica Jones, MD

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Jessica Jones, Assistant Professor of Oncology at the University of Texas (UT) Health System, sat down with Oncology Data Advisor to discuss her work in cancer detection and cancer prevention in Black women with a higher risk of developing breast cancer and bridging the racial gap in breast cancer morbidity and mortality with early detection and prevention.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.

Continue reading

Addressing Racial Disparities in Multiple Myeloma Treatment Outcomes With Rahul Banerjee, MD, and Samer Al Hadidi, MD, MS, FACP

Research has shown that Black American patients with multiple myeloma experience significant disparities in treatment patterns and outcomes compared with White patients. In this interview, Oncology Data Advisor editorial board member Dr. Rahul Banerjee speaks with Dr. Samer Al Hadidi, Assistant Professor at the University of Arkansas Medical School and a leading researcher in the field of multiple myeloma treatment disparities. Dr. Al Hadidi explains the differences in disease biology and treatment outcomes experienced by Black patients and shares solutions for closing this gap and ensuring equal access to care for all patients with multiple myeloma.  

Continue reading